| Literature DB >> 29301539 |
Linda Nguyen1, Ronit Mesterman1, Jan Willem Gorter2.
Abstract
BACKGROUND: In the management of hypertonicity in children with cerebral palsy (CP), goals should be clearly identified in order to evaluate the effectiveness of botulinum toxin A (BoNT-A) treatment, specifically in non-ambulatory children and adolescents, Gross Motor Function Classification System (GMFCS), level IV or V. A retrospective chart review (Mesterman et al., 2013) identified the need for the development of a set of specific and meaningful goals linked to the International Classification of Functioning, Disability and Health (ICF) for future goal setting and evaluation in this population. Our objective is to create an inventory of goals based on the ICF framework that captures the needs and values of families with children with CP.Entities:
Keywords: Botulinum toxin A; Cerebral Palsy; Child; Disability and Health; Family-centred care; International Classification of Functioning; Needs assessment
Mesh:
Substances:
Year: 2018 PMID: 29301539 PMCID: PMC5755464 DOI: 10.1186/s12887-017-0974-x
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Subject characteristics
| Characteristics | Subjects, |
|---|---|
| Age (in years | |
| mean ± SD | 11.2 ± 4.3 |
| Age range | 5 -17 |
| Gender, n (%) | |
| Male | 13 (65) |
| Female | 7 (35) |
| GMFCS, n (%) | |
| level IV | 10 (50) |
| level V | 10 (50) |
| MACS, n (%) | |
| level I | 1 (5) |
| level II | 2 (10) |
| level III | 3 (15) |
| level IV | 5 (25) |
| level V | 9 (45) |
| aCFCS, | |
| level I | 3 (16) |
| level II | 2 (10) |
| level III | 1 (5) |
| level IV | 6 (32) |
| level V | 7 (37) |
| Cognitive impairments | 20 (100%) |
aData unavailable for one participant
Fig. 1Development of the inventory list of goals in the context botulinum toxin treatment
Goals for botulinum toxin A treatment according to International Classification of Functioning, Disability and Health component domain [6]
| Specific goals identified according to ICF component domain | Identified goals | |
|---|---|---|
| % | ||
| Body structure and function | ||
| Tone | 15 | 75 |
| To maintain and improve range of motion | ||
| Legs | 18 | 90 |
| Hip | 8 | 40 |
| Knees | 5 | 25 |
| Ankles | 5 | 25 |
| Arms | 6 | 30 |
| Shoulder | 3 | 15 |
| Elbow | 6 | 30 |
| Wrist | 3 | 15 |
| Fingers | 4 | 20 |
| Drooling | 3 | 15 |
| Pain | 6 | 30 |
| Bone Health | 3 | 15 |
| Activity | ||
| Mobility | ||
| Walking | 11 | 55 |
| Standing | 12 | 60 |
| Transfers | 10 | 50 |
| Dressing | 9 | 45 |
| Shoes and socks | 2 | 10 |
| Time taken for dressing | 8 | 40 |
| Eating | 3 | 15 |
| Hygiene | 11 | 55 |
| By patient | 1 | 5 |
| By care provider | 12 | 60 |
| Exercise tolerance | 12 | 60 |
| Manipulating switches | 4 | 20 |
| Hand function | 5 | 25 |
| Tolerating braces | 11 | 55 |
| Use of equipment | ||
| Walker | 8 | 40 |
| Wheelchair | 5 | 25 |
| Stander | 9 | 45 |
| Participation | ||
| Being able to participate and compete | 4 | 20 |
| E.g. wheelchair sports | 2 | 10 |
Abbreviation: ICF, International Classification of Functioning, Disability and Health
Fig. 2Main goals from BoNT-A treatment selected by parents
Description of BoNT-A injections in each child
| Participant | GMFCS Level | Number of BoNT-A injections before interview | Number of BoNT-A injections after interview | Area of BoNT-A injections | Changes after BoNT-A injections | Outcome |
|---|---|---|---|---|---|---|
| 1 | 4 | 6 | 5 | Lower and upper extremities | Ease of dressing | Positive |
| Able to sit more comfortably | ||||||
| Able to bear weight when transferring positions | ||||||
| Able to use assistive equipment | ||||||
| 2 | 4 | 1 | 0 | Lower extremity | No change | Negative |
| 3 | 4 | 1 | 1 | Lower extremity | No change | Negative |
| 4 | 4 | 5 | 7 | Lower extremity | Able to stand straighter | Positive |
| Able to sit in a wheelchair | ||||||
| Better sleep | ||||||
| 5 | 4 | 10 | 6 | Lower extremity | Able to sit in a wheelchair | Positive |
| Able to walk with a walker | ||||||
| 6 | 4 | 7 | 5 | Lower and upper extremities | Ease of diapering | Positive |
| Able to tolerate braces | ||||||
| 7 | 4 | 10 | 1 | Lower extremity | Reduced muscle tone | Positive |
| Decreased feeling of generalized pain | ||||||
| Better sleep | ||||||
| 8 | 4 | 8 | 4 | Lower extremity | Reduced tone | Positive |
| Able to use a stander | ||||||
| 9 | 4 | 11 | 1 | Lower extremity | No change | Negative |
| 10 | 4 | < 3a | 1 | Lower extremity | Able to use assistive devices for walker | Positive |
| Ease of transfers in position | ||||||
| 11 | 5 | 1 | 3 | Lower and upper extremities | Ease of dressing | Positive |
| Better sleep | ||||||
| 12 | 5 | 1 | 0 | Lower extremity | No change | Negative |
| 13 | 5 | 5 | 7 | Lower extremity | Ease of standing with a stander | Positive |
| Better sleep | ||||||
| 14 | 5 | 15 | 4 | Lower extremity | Reduced tone | Positive |
| Able to use a walker | ||||||
| Able to participate in horseback riding | ||||||
| 15 | 5 | 8 | 2 | Lower extremity | Increased range of motion | Positive |
| Ease of personal hygiene, including diapering and bathing | ||||||
| Ease of dressing | ||||||
| 16 | 5 | 8 | 6 | Lower extremity | Personal hygiene | Positive |
| Ease of dressing and transfers | ||||||
| 17 | 5 | 1 | 1 | Lower extremity | Not documented | Neutral |
| 18 | 5 | 7 | 4 | Lower and upper extremities | Increased range of motion and stretching | Positive |
| Ease of diapering | ||||||
| 19 | 5 | 13 | 7 | Lower and upper extremities | Ease of dressing and bathing | Positive |
| Able to participate in swimming | ||||||
| 20 | 5 | < 3a | < 3a | Lower extremity | Not documented | Positive |
aExact frequency could not be retrieved at the time of the study